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ABSTRACT
OBJECTIVE: To estimate the proportion and total number of the general adult population who 
may be at higher risk of severe Covid-19 in Brazil.
METHODS: We included 51,770 participants from a nationally representative, household-based 
health survey (PNS) conducted in Brazil. We estimated the proportion and number of adults 
(≥ 18 years) at risk of severe Covid-19 by sex, educational level, race/ethnicity, and state based 
on the presence of one or more of the following risk factors: age ≥ 65 years or medical diagnosis 
of cardiovascular disease, diabetes, hypertension, chronic respiratory disease, cancer, stroke, 
chronic kidney disease and moderate to severe asthma, smoking status, and obesity.
RESULTS: Adults at risk of severe Covid-19 in Brazil varied from 34.0% (53 million) to 54.5% 
(86 million) nationwide. Less-educated adults present a 2-fold higher prevalence of risk factors 
compared to university graduated. We found no differences by sex and race/ethnicity. São 
Paulo, Rio de Janeiro, Minas Gerais, and Rio Grande do Sul were the most vulnerable states in 
absolute and relative terms of adults at risk. 
CONCLUSIONS: Proportion and total number of adults at risk of severe Covid-19 are high 
in Brazil, with wide variation across states and adult subgroups. These findings should be 
considered while designing and implementing prevention measures in Brazil. We argue that 
these results support broad social isolation measures, particularly when testing capacity for 
SARS-CoV-2 is limited.
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INTRODUCTION
The World Health Organization (WHO) suggests that most people infected with the virus 
may develop mild or uncomplicated (80%) coronavirus disease 2019 (Covid-19), while the 
remaining 20% may develop its severe variation, requiring hospitalization (14%) or intensive 
care unit (6%)1. Established risk factors for severe disease among inpatients with Covid-19 in 
China included older age2,3 and serious medical conditions such as cardiovascular disease2–4, 
diabetes2–4, chronic respiratory disease (in particular chronic obstructive pulmonary disease 
– COPD)2, hypertension2,4, cancer2,5, and cerebrovascular disease3,4. Recent findings from 
United States (US) and Europe confirmed these risk factors and proposed new ones, such 
as chronic kidney disease, obesity, asthma and smoking6–9.
The emergence of a highly transmissible pathogen10 in a completely susceptible population 
has resulted in an exponential growth of new cases worldwide and a wide dissemination 
across the globe. As of April 12, 2020, the number of SARS-CoV-2 infections was above 
1.8 million, reported in 185 countries/regions of the world11. High- and low-income regions 
are already facing overload of health facilities and facing scarcity of resources to fight the 
pandemic. In lower resource settings, countries have a short time to prepare prevention and 
management strategies, including the identification of high-risk populations and regions 
within countries. 
Herein, we propose a calculation of the proportion and total number of the general adult 
population who may be at higher risk for severe Covid-19, based on routinely collected data 
from a nationwide, household-based survey in Brazil. We argue that this method could be 
easily and rapidly applied within and across countries in order to craft tailored prevention 
strategies such as social isolation.
METHODS
We obtained data from the most recent representative, household-based survey conducted 
in Brazil, the National Health Survey (PNS, 2013 – Pesquisa Nacional de Saúde), carried 
out by the Ministry of Health in partnership with the Brazilian Institute of Geography 
and Statistics (IBGE). The PNS enrolled 62,202 adults who responded to a comprehensive 
questionnaire about several health-related issues. In this study, we included 51,770 
participants who responded to the questionnaire about medical diagnosis and lifestyle 
risk factors, and had their weight and height measured. Further details about PNS have 
been described elsewhere12. 
Risk Factors for Severe Covid-19
We included risk factors for severe Covid-19 based on currently available information from 
clinical studies and expertise2–9, and for which exposure data were available in the PNS12. Age 
and medical diagnosis of cardiovascular disease, diabetes, hypertension, chronic respiratory 
disease, cancer, stroke, chronic kidney disease and asthma were assessed. We also obtained 
time (in years) since cancer diagnosis and treatment/medication use for chronic kidney 
disease (e.g. dialysis) and asthma to match definitions from the literature (e.g. moderate 
to severe asthma). Information about age, smoking status and measured body mass index 
(BMI) were also obtained/estimated. 
Prevalence of one or more risk factors for severe Covid-19 was estimated using two 
criteria (Table 1). Criterion 1 included first identified and established risk factors for severe 
Covid-19 such as age ≥ 65 years or medical diagnosis of cardiovascular disease, diabetes, 
hypertension, chronic respiratory disease, cancer or stroke. Although ≥ 60 years have 
been used to define older adults in Brazil, herein we considered ≥ 65 years to match the 
definition of risk factors for Covid-19 obtained from the literature and allow comparisons 
with other publications2–9. Criterion 2 additionally included diagnosis of chronic kidney 
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disease and moderate to severe asthma, smoking status (current smokers) and obesity 
(BMI ≥ 30 kg/m2). Criterion 2 was used to provide a higher sensitivity for the proportion of 
adults at risk of severe illness. Denominator for both criteria 1 (n = 52,511) and 2 (n = 51,770) 
included all participants with complete questionnaires. We also estimated the sum of all 
risk factors for severe illness (0, 1, 2, 3 + risk factors).
Sociodemographic Covariates
Information on covariates including sex, race/ethnicity, educational level, and Brazilian state 
(26 states and the Federative District) were obtained to describe the proportion of adults at 
risk of severe Covid-19 by population strata. We also retrieved the total projected number 
of the Brazilian adult population (≥ 18 years) in 2020 by sex and state from the IBGE13.  
Statistical Analysis
We estimated the prevalence and 95% confidence intervals of adults at risk for severe 
Covid-19 (Criterion 1 and Criterion 2) by sex, education, race/ethnicity and Brazilian state. 
We performed sensitivity analyses for prevalence by considering two other definitions for 
older adults (≥ 60 years and ≥ 70 years). In order to obtain the total number of adults at risk 
of severe illness, we applied the prevalence to the number of adult’s population (≥ 18 years) 
by sex and state. The sample design was considered for all analyses using the survey prefix 
command (svy) in Stata version 15.0.
Table 1. Definition of risk factors for severe Covid-19 according to two different proposed criteria.
Risk factors Definition
Presence of risk factor for severe Covid-19
Criterion 1 Criterion 2
Age in years ≥ 65 years ≥ 65 years
Cardiovascular disease
Has a doctor ever diagnosed you with 
a heart disease such as infarction, 
angina, heart failure or other?
Yes Yes
Diabetes




Has a doctor ever diagnosed you 




Has a doctor already diagnosed 
you with any lung disease such as 
pulmonary emphysema, chronic 




Has any doctor ever diagnosed you 
with cancer (excluding skin cancer)?
Yes Yes
How many years ago since your 
cancer diagnosis?
< 5 years < 5 years
Stroke
Has any doctor ever diagnosed you 
with stroke?
Yes Yes
Obesity Measured body mass index No ≥ 30 kg/m2
Smoking Current smoker No
Yes 
(daily or less than daily)
Chronic kidney disease
Has any doctor ever diagnosed you 
with chronic kidney disease?
No Yes
What do you currently do or 




peritoneal dialysis, took 
medication, underwent 
a kidney transplant
Moderate to severe asthma
Has any doctor ever diagnosed 
you with asthma (or asthmatic 
bronchitis)?
No Yes
What do you currently do because 
of asthma? 
No
Use of inhalers, aerosol 
or tablets
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RESULTS
Participants characteristics and risk factors for severe illness are presented by age group 
(Table 2). Compared with younger participants, older adults (≥ 65 years) were less educated, 
more likely women, white and presented higher prevalence of risk factors for severe Covid-19, 
except for smoking. Prevalence of one or more risk factors for severe illness was 47.3% in 
younger vs 75.9% in older adults. 
Proportion and total number of adults at risk for severe Covid-19 in Brazil varied from 
34.0% (53 million adults) to 54.5% (86 million adults) (Table 3). Overall, 46% of the sample 
presented no risk factor, 30.0% with one, 15.0% with two, and 9% with 3 or more risk 
factors for severe illness. Sensitivity analyses considering older adults ≥ 60 years and 
≥ 70 years suggested that prevalence could vary from 36.7%–56.2% to 32.3%–53.3%, 
respectively (Table 4). 




< 65 years ≥ 65 years
Number of participants 23.838 27.932 51.770
Mean age, years (se) 39.7 (11.4) 73.5 (14.1) 44.3 (15.0)
Sex (%)
Men 45.4 42.9 45.0
Education (%)
None or incomplete primary education 15.1 67.0 22.2
Complete primary or incomplete secondary education 27.2 14.0 25.4
Complete secondary education or incomplete 
undergraduate course
42.7 10.3 38.3
University Graduate 15.0 8.7 14.1
Race/ethnicity (%)
White 48.3 55.9 49.4
Non-white 51.7 44.1 50.6
Risk factors for Severe Covid-19 (%)
Cardiovascular disease 3.4 13.0 4.7
Diabetes 5.1 20.7 7.2
Chronic respiratory disease 1.5 4.4 1.9
Hypertension 18.8 55.3 23.7
Cancer 0.6 2.2 0.8
Stroke 1.0 6.1 1.7
Obesity (BMI ≥30 kg/m2) 22.0 22.7 22.1
Smoking 14.6 9.6 13.9
Chronic kidney disease 0.7 2.0 0.9
Moderate to severe asthma 1.5 1.7 1.5
Number of risk factors for severe Covid-19* (%)
None 52.7 24.1 48.8
1 30.9 35.1 31.5
2 12.0 25.2 13.8
3+ 4.4 15.6 5.9
SE: standard error
* Diagnosis of cardiovascular disease, diabetes, chronic respiratory disease, hypertension, cancer (< 5 years 
of diagnosis), stroke, obesity (BMI ≥ 30 kg/m2), current smoking, chronic kidney disease (diagnosis and under 
hemodialysis, peritoneal dialysis, taking medication or did a kidney transplant), moderate to severe asthma 
(diagnosis and taking inhalers, aerosol or tablets)
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Proportion of adults at risk for severe Covid-19 was 2-fold higher in less educated participants 
compared with university graduated. We found no differences in prevalence estimates by sex 
and race/ethnicity (Table 3). Estimates varied widely across states, with higher prevalence 
Table 3. Prevalence of one or more risk factor for severe Covid-19 among the Brazilian general adult 
population by risk criteria and sociodemographic characteristics, PNS 2013.
Characteristics
Prevalence of one or more risk factors for severe Covid-19
Criterion 1 (n = 52,511) Criterion 2 (n = 51,770)
Prevalence (%) 95%CI Prevalence (%) 95%CI
Total 34.0 33.2–34.7 54.4 53.6–55.2
Sex
Men 31.6 30.5–32.8 53.3 52.1–54.5
Women 35.9 34.9–36.8 55.4 54.3–56.4
Education
None or incomplete primary 
education
66.3 64.7–67.9 80.2 78.9–81.4
Complete primary or incomplete 
secondary education
30.5 29.2–31.9 55.0 53.5–56.5
Complete secondary education or 
incomplete undergraduate course
20.4 19.4–21.4 42.2 40.9–43.6
University Graduate 27.0 25.1–29.1 46.1 44.1–48.3
Race/ethnicity
White 34.9 33.8–36.0 55.0 53.9–56.2
Non-white 33.1 21.1–34.0 53.9 52.8–54.9
Criterion 1: age ≥ 65 years or diagnosis of cardiovascular disease, diabetes, chronic respiratory disease, 
hypertension, cancer (< 5 years of diagnosis), or stroke
Criterion 2: additionally, obesity (BMI ≥ 30 kg/m2), current smoking, chronic kidney disease (diagnosis and under 
Hemodialysis, peritoneal dialysis, taking medication or did a kidney transplant), moderate to severe asthma 
(diagnosis and taking inhalers, aerosol or tablets)
Table 4. Sensitivity analysis: prevalence of one or more risk factors for severe Covid-19 among the Brazilian general adult population by 
risk criteria, definitions of older age and sociodemographic characteristics in Brazil, PNS 2013.
Characteristics
Risk factors for severe Covid-19
Criterion 1 (n = 52,511) Criterion 2 (n = 51,770)
Older age defined as 
≥ 60 years
Older age defined as  
≥ 70 years
Older age defined as  
≥ 60 years














Total 36.7 36.0–37.5 32.3 31.6–33.0 56.2 55.3–57.0 53.3 52.5–54.0
Sex
Men 34.5 33.3–35.6 30.0 28.9–31.1 54.9 53.7–56.1 52.2 51.0–53.4
Women 38.6 37.6–39.5 34.2 33.3–35.1 57.2 56.1–58.2 54.2 53.2–55.2
Education
None or incomplete primary 72.0 70.4–73.4 62.2 60.5–63.8 83.4 82.3–84.6 77.5 76.2–78.8
Complete primary or 
incomplete secondary
32.2 30.9–33.6 29.3 28.0–30.6 56.2 54.6–57.7 54.1 52.5–55.6
Complete secondary or 
incomplete university
22.1 21.1–23.2 19.8 18.8–20.8 43.4 42.0–44.7 41.8 40.4–43.2
University Graduate 30.0 28.0–32.1 25.6 23.7–27.5 48.1 45.9–50.2 45.1 43.0–47.2
Race/ethnicity
White 38.0 36.9–39.2 33.1 32.0–34.2 57.0 55.8–58.2 53.8 52.6–54.9
Non-white 35.5 34.5–36.5 31.6 30.6–32.5 55.3 54.3–56.3 52.8 51.8–53.9
Criterion 1: age group or diagnosis of cardiovascular disease, diabetes, chronic respiratory disease, hypertension, cancer (< 5 years of diagnosis), or stroke; 
Criterion 2: additionally obesity (BMI ≥ 30 kg/m2), current smoking, chronic kidney disease (diagnosis and under hemodialysis, peritoneal dialysis, taking 
medication or did a kidney transplant), moderate to severe asthma (diagnosis and taking inhalers, aerosol or tablets).
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in the South and Southeast regions of the country (Figure). The highest prevalence was 
39.5%–58.4% in Rio Grande do Sul, followed by 36.0–55.8% in Rio de Janeiro and 35.6%–58.2% 
in São Paulo. The lowest prevalence was found in Amapá (23.4%–45.9%), followed by Roraima 
(25.0%–48.6%) and Amazonas (25.1%–48.7%). The highest number of adults at risk of severe 
illness was found in São Paulo (17-21 million), Minas Gerais (6–9 million) and Rio de Janeiro 












































































a Criterion 1 (C1): age ≥ 65 years or diagnosis of cardiovascular disease, diabetes, chronic respiratory disease, 
hypertension, cancer (&lt;5 years of diagnosis), or stroke;  
b Criterion 2 (C2): additionally, obesity (BMI ≥ 30 kg/m2), current smoking, chronic kidney disease (diagnosis and 
under hemodialysis, peritoneal dialysis, taking medication or did a kidney transplant), moderate to severe asthma 
(diagnosis and taking inhalers, aerosol or tablets).
Figure. Adults at high-risk of severe Covid-19 in Brazil by state and risk criteria.
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DISCUSSION
In this study, we estimated that a third (53 million) to over a half (86 million) of Brazilian 
adults present at least one risk factor for severe Covid-19. Our findings point to high 
prevalence of serious medical conditions in younger, but mostly, among older adults. Less 
educated adults present 2-fold higher prevalence of risk factors compared with university 
graduated. São Paulo, Rio de Janeiro, Minas Gerais and Rio Grande do Sul were the most 
vulnerable states in absolute and relative terms of adults at high-risk. Contrasts between 
South and Southeast vs North and Northeast regions might be due to different age structure, 
prevalence of health condition and/or access to medical diagnosis and care.
Estimating the proportion of the population at risk for severe Covid-19 within and across 
countries is key to improve prevention measures. However, to our knowledge, these 
estimates are still sparse worldwide. In the US, it was estimated that four in ten (37.6%) 
adults ≥ 18 years may be at high-risk of severe Covid-1914. During the pandemic, time is 





Prevalence of one or more risk factors for severe Covid-19, %
Criterion 1 (n = 52,511) Criterion 2 (n = 51,770)
Prevalence (%) 95%CI N at risk Prevalence (%) 95%CI N at risk 
Brazil 158,255,554 34.0 33.2–34.7 53,806,888 54.4 53.6–55.2 86,091,021
Brazilian States
Rondônia 1,296,218 29.6 26.7–32.7 383,681 50.3 47.3–53.2 651,998
Acre 581,754 28.1 25.3–31.0 163,473 50.0 46.8–53.2 290,877
Amazonas 2,769,201 25.1 22.6–27.8 695,069 48.7 45.7–51.7 1,348,601
Roraima 430,939 25.0 22.3–27.9 107,735 48.6 45.0–52.2 209,436
Pará 5,971,477 26.2 23.2–29.3 1,564,527 45.2 41.8–48.7 2,699,108
Amapá 570,298 23.4 20.2–26.9 133,450 45.9 41.6–50.3 261,767
Tocantins 1,125,023 33.1 29.0–37.6 372,383 52.2 48.7–55.7 587,262
Maranhão 4,873,279 30.0 26.3–34.0 1,461,984 48.5 43.9–53.0 2,363,540
Piauí 2,383,425 32.7 29.4–36.1 779,380 53.0 49.6–56.3 1,263,215
Ceará 6,788,403 33.8 31.0–36.7 2,294,480 53.7 50.8–56.6 3,645,372
Rio Grande do Norte 2,632,403 33.2 30.2–36.3 873,958 52.9 49.7–56.1 1,392,541
Paraiba 2,984,647 33.4 30.6–36.3 996,872 49.0 46.0–51.9 1,462,477
Pernambuco 7,035,040 33.2 30.7–35.8 2,335,633 53.4 50.8–55.9 3,756,711
Alagoas 2,377,983 31.7 28.6–35.0 753,821 53.5 49.7–57.3 1,272,221
Sergipe 1,688,955 30.8 28.0–33.8 520,198 50.0 46.7–53.2 844,478
Bahia 11,044,986 30.3 26.8–34.1 3,346,631 48.9 44.8–53.0 5,400,998
Minas Gerais 16,425,183 35.6 33.1–38.2 5,847,365 55.1 52.0–58.2 9,050,276
Espírito Santo 3,047,439 31.5 27.6–35.6 959,943 48.1 43.6–52.7 1,465,818
Rio de Janeiro 13,419,464 36.0 33.8–38.1 4,831,007 55.8 53.6–58.0 7,488,061
São Paulo 35,414,776 35.6 33.7–37.4 12,607,660 58.2 56.2–60.2 20,611,400
Paraná 8,736,014 34.9 31.7–38.2 3,048,869 57.1 53.3–60.9 4,988,264
Santa Catarina 5,578,842 34.1 30.2–38.2 1,902,385 55.9 51.6–60.1 3,118,573
Rio Grande do Sul 8,902,263 39.5 36.8–42.3 3,516,394 58.4 55.6–61.1 5,198,922
Mato Grosso do Sul 2,045,881 34.7 31.6–37.8 709,921 57.6 54.5–60.7 1,178,427
Mato Grosso 2,543,642 31.9 28.9–35.1 811,422 54.8 51.9–57.6 1,393,916
Goiás 5,277,383 34.4 31.5–37.4 1,815,420 52.0 49.1–54.9 2,744,239
Distrito Federal 2,310,636 29.9 27.3–32.5 690,880 49.2 46.3–52.1 1,136,833
N at risk: number of adults (≥18 years) at risk of severe Covid-19 
Criterion 1: age ≥ 65 years or diagnosis of cardiovascular disease, diabetes, chronic respiratory disease, hypertension, cancer (< 5 years of diagnosis), or 
stroke;  Criterion 2: additionally obesity (BMI ≥ 30 kg/m2), current smoking, chronic kidney disease (diagnosis and under Hemodialysis, peritoneal dialysis, 
taking medication or did a kidney transplant), moderate to severe asthma (diagnosis and taking inhalers, aerosol or tablets)
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limited and hence the use of existing health information to support countries’ response 
is imperative. These findings and methods to identify high-risk settings may be useful 
to plan and manage prevention strategies in Brazil and other low- to middle-income 
settings with routinely collected data from population-based surveys, but limited testing 
capacity for SARS-CoV-2.
The understanding of risk factors for severe Covid-19 has so far supported the implementation 
of prevention strategies. It is interesting to note that non-communicable diseases such as 
cardiovascular disease, cancer, respiratory diseases, and diabetes, which accounts for most 
of deaths globally15, play a role on worsening the impact of the Covid-19 pandemic. Since 
isolation of infected cases and contact tracing alone will not likely suffice to control the 
pandemic16, countries have largely implemented social isolation measures. The combination 
of different interventions such as case isolation, social distancing of the entire population, 
household quarantine, school closure and, ultimately, complete lockdown is predicted to 
have significant impact on transmission17. Protecting the groups that are most at risk18, 
such as older adults and people with comorbidities, by widely and temporarily refraining 
from engaging in social contact, remains imperative. As knowledge on the clinical course 
of Covid-19 advances, the understanding of risk factors for severe disease will be improved, 
and so will the estimates of most-at-risk populations. 
Our results have some limitations. Prevalence of risk factors for severe Covid-19 is likely 
underestimated due to self-reported medical diagnosis of comorbidities and smoking status. 
Underlying diseases have been associated with poorer prognosis among inpatients with 
Covid-19, but some people may have lower risk due to well-controlled blood pressure and 
serum glucose, for instance, which may have overestimated the proportion and number of 
adults at risk. Undiagnosed, asymptomatic diseases such as diabetes and hypertension are 
concerns, especially in low-income settings. This may partially explain differences of adults 
at risk between Brazilian states. Estimates considered the same weight for all risk factors 
assessed, which may not be applicable. Furthermore, other known risk factors for severe 
Covid-19 such as living in a nursing home or long-term care facility, and immunosuppression 
could not be captured in our study. Lastly, risk factors information date from 2013, the most 
recent representative, household-based health survey of Brazilian adults. The proportion 
of older adults has increased in Brazil in the past seven years, as well as the prevalence 
of obesity and other non-communicable diseases19, which may have underestimated our 
estimates. On the other hand, the prevalence of tobacco smoking has decreased, which may 
have overestimated the adults at risk of severe Covid-19.
In conclusion, proportion and total number of adults at risk of severe Covid-19 is high in 
Brazil, with wide variation across states and adult subgroups. These findings should be 
considered while designing and implementing prevention measures. We argue that these 
results support broad social isolation measures, particularly while testing capacity for 
SARS-CoV-2 is limited.
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